692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors

• Antonio Jimeno,
• Michael S Gordon,
• Howard Bernstein,
• Scott Loughhead,
• Jong Chul Park,
• Justin C Moser,
• Wade T Iams,
• Meredith Pelster,
• Kerry J Rodabaugh,
• Julia Jennings,
• Nathan Miselis,
• Marshelle S Warren,
• Victoria Villaflor,
• Melinda Morrison

Affiliations

Antonio Jimeno

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Michael S Gordon

HonorHealth Research Institute, Scottsdale, Arizona, USA

Howard Bernstein

10SQZ Biotechnologies, Watertown, MA, USA

Scott Loughhead

SQZ Biotechnologies, Watertown, MA, USA

Jong Chul Park

4Massachusetts General Hospital, Boston, MA, USA

Justin C Moser

1HonorHealth Research Instittue, Scottsdale, AZ, USA

Wade T Iams

9Vanderbilt University Medical Center, Nashville, TN, USA

Meredith Pelster

5Sarah Cannon Research Institute, Nashville, TN, USA

Kerry J Rodabaugh

7University of Nebraska Medical Center, Omaha, NE, USA

Julia Jennings

10SQZ Biotechnologies, Watertown, MA, USA

Nathan Miselis

8SQZ Biotechnologies, Watertown, MA, USA

Marshelle S Warren

10SQZ Biotechnologies, Watertown, MA, USA

Victoria Villaflor

5City of Hope, Duarte, CA, USA

Melinda Morrison

8SQZ Biotechnologies, Watertown, MA, USA